Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy.

@article{Moehler2001SalvageTF,
  title={Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy.},
  author={Thomas M. Moehler and Kai Neben and Axel Benner and Gerlinde Egerer and Fatime Krasniqi and Anthony D. Ho and Hartmut Goldschmidt},
  journal={Blood},
  year={2001},
  volume={98 13},
  pages={3846-8}
}
The feasibility and efficacy of a combination of thalidomide, cyclophosphamide, etoposide, and dexamethasone were studied in 56 patients with poor-prognosis multiple myeloma. Of 50 patients evaluable for response, 4% achieved complete response (CR), 64% partial response (PR), 18% minimal response (MR), 6% stable disease (SD), and 8% progressive disease (PD… CONTINUE READING